Title:
PYRAZOLOPYRIDINE COMPOUNDS AS SELECTIVE BTK KINASE INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2021/057893
Kind Code:
A1
Abstract:
Disclosed are a class of BTK kinase inhibitor compounds with a high activity and a high selectivity and the use thereof in the preparation of a drug for treating BTK target-related diseases. Specifically, disclosed are a compound shown as formula (I), and an isomer and a pharmaceutically acceptable salt thereof.
Inventors:
SHEN CHUNLI (CN)
WEI XIAWEI (CN)
WU CHENGDE (CN)
HU GUOPING (CN)
LI JIAN (CN)
CHEN SHUHUI (CN)
WEI XIAWEI (CN)
WU CHENGDE (CN)
HU GUOPING (CN)
LI JIAN (CN)
CHEN SHUHUI (CN)
Application Number:
PCT/CN2020/117690
Publication Date:
April 01, 2021
Filing Date:
September 25, 2020
Export Citation:
Assignee:
MEDSHINE DISCOVERY INC (CN)
International Classes:
C07D487/04; A61K31/4353; A61P35/00; C07D471/04
Domestic Patent References:
| WO2015095099A1 | 2015-06-25 | |||
| WO2018033091A1 | 2018-02-22 |
Foreign References:
| CN105399756A | 2016-03-16 | |||
| CN110272416A | 2019-09-24 | |||
| CN105017256A | 2015-11-04 | |||
| CN201910919180A | 2019-09-26 | |||
| CN202010330226A | 2020-04-24 |
Other References:
See also references of EP 4036095A4
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: